Prevention of hyperacute xenograft rejection by intravenous immunoglobulin.
Magee
J C
JC
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710.
Collins
B H
BH
Harland
R C
RC
Bollinger
R R
RR
Frank
M M
MM
Platt
J L
JL
D000208:Acute Disease; D000818:Animals; D004730:Endothelium, Vascular / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology; D007075:Immunoglobulin M / Q000378:metabolism; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008252:Macaca fascicularis; D010215:Papio; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*; D016042:Transplantation, Heterotopic
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous